Top Biotechnology companies in Italy by Debt to Equity Ratio
Italy
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1.07
|
Dec. 31, 2023 | USD 60.99 | 0.24% |
|
Italy |
|
| 2 |
0.77
|
Dec. 31, 2023 | USD 106.54 | -0.80% |
|
Italy |
|
| 3 |
0.67
|
Dec. 31, 2023 | USD 40.97 | 0.66% |
|
Italy |
|
| 4 |
0.46
|
Dec. 31, 2023 | USD 7.72 | -3.19% |
|
Italy |
|
| 5 |
0.16
|
Dec. 31, 2023 | USD 18.53 | 2.23% |
|
Italy |
|
| 6 |
0.04
|
Dec. 31, 2023 | USD 1.99 | -0.60% |
|
Italy |
|
| 7 |
-1.62
|
Dec. 31, 2023 | USD 10.28 | -2.46% |
|
Italy |
Frequently Asked Questions
-
Which Biotechnology company in Italy has the highest Debt to Equity Ratio ?
The Biotechnology company in Italy with the highest Debt to Equity Ratio is Recordati Industria Chimica e Farmaceutica S.p.A. (Milan Stock Exchange: REC.MI) at 1.07.
-
Which Biotechnology company in Italy has the lowest Debt to Equity Ratio ?
The Biotechnology company in Italy with the lowest Debt to Equity Ratio is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -1.62.
-
What are the top 10 Biotechnology companies in Italy by Debt to Equity Ratio ?
The top 10 Biotechnology companies in Italy by Debt to Equity Ratio are Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., SOL S.p.A., Franchetti S.p.A., Philogen S.p.A., Arterra Bioscience and Newron Pharmaceuticals S.p.A..
-
What are the bottom 10 Biotechnology companies in Italy by Debt to Equity Ratio ?
The bottom 10 Biotechnology companies in Italy by Debt to Equity Ratio are Newron Pharmaceuticals S.p.A., Arterra Bioscience, Philogen S.p.A., Franchetti S.p.A., SOL S.p.A., DiaSorin S.p.A. and Recordati Industria Chimica e Farmaceutica S.p.A..
